Project Details
Description
Open label, single arm safety prospective cohort study of dabigatran etexilate for secondary prevention of venous thromboembolism in children from 0 to less than 18 years
| Status | Finished |
|---|---|
| Effective start/end date | 4/1/16 → 3/31/20 |
Funding
- Boehringer-Ingelheim Pharmaceuticals
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.